Skip to main content
DongKoo Bio & Pharma Co., Ltd. logo

DongKoo Bio & Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 006620 ISIN · KR7006620009 KO Manufacturing
Open in API
Filings indexed 209 across all filing types
Latest filing 2026-04-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 006620

About DongKoo Bio & Pharma Co., Ltd.

https://www.dongkoo.com/eng/

DongKoo Bio & Pharma Co., Ltd. is a biopharmaceutical company that manufactures and sells a range of pharmaceuticals and health supplements. The company holds a leading position in the dermatology prescription market, with a product portfolio that includes antihistamines, analgesics, antipyretics, and digestants. Strategically expanding beyond traditional pharmaceuticals, DongKoo Bio & Pharma is focused on the biotechnology sector, particularly the development of stem cell-based therapies. This growth is pursued through an "Open Innovation" model to build a pipeline of differentiated products, supported by its research centers and PIC/s compliant GMP manufacturing facilities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a “주식등의 대량보유상황보고서(일반)” filed under Korea’s Capital Markets Act, detailing large shareholding positions, related changes, and threshold crossings. It is clearly a major shareholding notification rather than an annual report, earnings release, or board change. Therefore, it matches the Major Shareholding Notification category.
2026-04-02 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal notification filed with the Financial Services Commission and Korea Exchange regarding the appointment, reappointment, and resignation of outside directors, listing names, dates, and positions. This is clearly an announcement of changes in the company’s board of directors, fitting the definition of a Board/Management Information filing.
2026-04-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory announcement (“신고”) addressed to the Financial Services Commission and the Korea Exchange, detailing the terms and conditions of granting stock purchase options to directors and employees (new share allotment, treasury share allotment or cash settlement). It’s not a financial report, earnings release, management change, or legal proceeding report. It pertains to the issuance of share options and thus fits the definition of a capital change announcement. Therefore, it should be classified as Share Issue/Capital Change (SHA).
2026-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official results of a regular shareholders’ meeting held on 2026-03-31, detailing approval of financial statements, dividend resolutions, director elections, vote counts and approval rates for each agenda item. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for Dong-A ST (Dong-A Socio Holdings subsidiary/related entity) for the fiscal year ending December 31, 2025. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Comprehensive Income Statement, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This is a comprehensive financial audit document, not a summary or an announcement, fitting the 'Audit Report' (AR) category. FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a submission of a 회사 감사보고서 (“감사보고서 제출”), containing detailed auditor’s opinions (적정), financial statement figures (assets, liabilities, revenues, profits) for both consolidated and standalone statements, the audit firm name, and audit receipt date. It is not an announcement of an upcoming report or a short link notice but the actual audit report information. This matches the “Audit Report / Information” category (AR). FY 2025
2026-03-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.